Publication

Article

Digital Edition

Ophthalmology Times: July 15, 2020
Volume45
Issue 12

Diagnosing a 'down looker'

Author(s):

Jon Carter

Diagnosing a 'down looker'

Diagnosing a 'down looker'


See more Optic Relief content by Jon Carter

Download Issue PDF
Articles in this issue
Aspheric, aberration-free IOL leverages technology for performance
Aspheric, aberration-free IOL leverages technology for performance
Emerging opportunities — and risks — with telehealth in a pandemic
Emerging opportunities — and risks — with telehealth in a pandemic
Figure 1: The Tecnis Toric II lens has an edge of the haptic that is unpolished to create more friction
Toric stability: A minor change with a major impact for patients
Teaching AI algorithms to identify corneal pathology: The future is now
Teaching AI algorithms to identify corneal pathology: The future is now
Diagnosing a 'down looker'
Diagnosing a 'down looker'
A hands-free treatment regimen is found to be safe and effective compared with a conventional eyedrop regimen.
Dropless, hands-free regimen key for patients
Amid pandemic, friendly bugs can help protect the eye from infection
Amid pandemic, friendly bugs can help protect the eye from infection
(Figure 1) These images show the remaining island of residual tissue targeted by gene therapy at treatment. The image at left is 1 week after treatment. (Photos courtesy of M. Dominik Fischer, MD, PhD)
Gene therapy offers hope for choroideremia
Machine-learning algorithms could help predict course of NPDR
Machine-learning algorithms could help predict course of NPDR
Thyroid eye disease: Not limited to visual impairment
Thyroid eye disease: Not limited to visual impairment
Beating burnout with camaraderie
Beating burnout with camaraderie
Themistocles: Everyone's second chance
Themistocles: Everyone's second chance
IOP homeostasis in glaucoma: Looking below the surface
IOP homeostasis in glaucoma: Looking below the surface
Clearing hurdles to large scale telemedicine adoption
Clearing hurdles to large scale telemedicine adoption
A patient's vision loss leads to another diagnosis
The eyes offer conjunctival clue to COVID-19

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
Related Content
Viridian Therapeutics announces positive long-term durability data for veligrotug for the treatment of active thyroid eye disease
May 20th 2025

Viridian Therapeutics announces positive long-term durability data for veligrotug for the treatment of active thyroid eye disease

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Astigmatism in Hong Kong children increased substantially following COVID-19 era restrictions
May 20th 2025

Astigmatism in Hong Kong children increased substantially following COVID-19 era restrictions

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Therini Bio raises $39 million in a Series A extension financing
May 19th 2025

Therini Bio raises $39 million in a Series A extension financing

Sylentis releases topline results from phase 2a of SYL1801
May 19th 2025

Sylentis releases topline results from phase 2a of SYL1801

© 2025 MJH Life Sciences

All rights reserved.